Skip to main content
  • Low-Risk TAVR in Spotlight at ACC

    Prevention guidelines, Apple Watch also on parade in New Orleans

    NEW ORLEANS -- The future of aortic valve procedures will be decided here at the American College of Cardiology meeting with presentation of the PARTNER 3 and CoreValve trials in low-surgical risk patients.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details